142 related articles for article (PubMed ID: 3301244)
21. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
Shapiro W; DiBianco R; Thadani U
Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
[TBL] [Abstract][Full Text] [Related]
22. Bepridil and valproate retard Na+ reactivation in Myxicola.
Schauf CL
Eur J Pharmacol; 1987 Jun; 138(1):89-93. PubMed ID: 3113983
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
24. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
Kumar S; Hall RJ
Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
[TBL] [Abstract][Full Text] [Related]
25. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
[TBL] [Abstract][Full Text] [Related]
27. [Bepridil in stable angina of effort: a double-blind comparison with verapamil].
Matteoli S; Trappolini M; Galli V; Federici AR; Borgia MC; Greco V
Cardiologia; 1988 Apr; 33(4):413-8. PubMed ID: 3044589
[No Abstract] [Full Text] [Related]
28. Combination propranolol and bepridil therapy in stable angina pectoris.
Frishman WH; Charlap S; Farnham DJ; Sawin HS; Michelson EL; Crawford MH; DiBianco R; Kostis JB; Zellner SR; Michie DD
Am J Cardiol; 1985 Mar; 55(7):43C-49C. PubMed ID: 3883741
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive effects of a calcium antagonist, bepridil, in patients with essential hypertension.
Aoki K; Sato K
Jpn Heart J; 1986 Sep; 27(5):693-9. PubMed ID: 3493359
[TBL] [Abstract][Full Text] [Related]
30. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
[TBL] [Abstract][Full Text] [Related]
31. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
Haerer VW; Stauch M
Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
[TBL] [Abstract][Full Text] [Related]
32. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
33. Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States.
Singh BN
Am J Cardiol; 1992 Apr; 69(11):68D-74D. PubMed ID: 1532469
[TBL] [Abstract][Full Text] [Related]
34. Bepridil hydrochloride for treatment of benign or potentially lethal ventricular arrhythmias.
Nestico PF; Morganroth J; Horowitz LN; Mulhern C
Am J Cardiol; 1986 Nov; 58(10):1001-4. PubMed ID: 2430441
[TBL] [Abstract][Full Text] [Related]
35. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
[TBL] [Abstract][Full Text] [Related]
36. [A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].
Canicave JC; Deu J; Jacq J; Paillet R
Therapie; 1980; 35(5):607-12. PubMed ID: 6970998
[No Abstract] [Full Text] [Related]
37. Nine cases of torsade de pointes with bepridil administration.
Manouvrier J; Sagot M; Caron C; Vaskmann G; Leroy R; Reade R; Ducloux G
Am Heart J; 1986 May; 111(5):1005-7. PubMed ID: 3486580
[No Abstract] [Full Text] [Related]
38. The effects of bepridil, compared with calcium-channel inhibitors and calmodulin antagonists on both spontaneous activity and contractions induced by potassium or phenylephrine in rat portal vein.
Campbell JK; Winslow E; Marshall RJ
Eur J Pharmacol; 1986 Dec; 132(2-3):187-96. PubMed ID: 3493163
[TBL] [Abstract][Full Text] [Related]
39. Effect of oral administration of a new calcium channel blocking agent, bepridil on antipyrine clearance in man.
Funck-Brentano C; Chaffin PL; Wilkinson GR; McAllister B; Woosley RL
Br J Clin Pharmacol; 1987 Oct; 24(4):559-60. PubMed ID: 3500736
[No Abstract] [Full Text] [Related]
40. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.
Kane KA; Winslow E
J Cardiovasc Pharmacol; 1980; 2(2):193-203. PubMed ID: 6171686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
